Search Results

Your search returned 6 results. You are on page 1 of 1.

Article
1 January 2010

Informed consent: Enforcing pharmaceutical companies’ obligations abroad

Author: Stacey B Lee, lecturer of business law and ethics in the Johns Hopkins Carey Business School, USA, Health and Human Rights Journal

The past several years have seen an evolution in the obligations of pharmaceutical companies conducting clinical trials abroad. Key players, such as international human rights organizations, multinational pharmaceutical companies, the United States...

Read more

Article
3 March 2009

[PDF] Human rights guidelines for pharmaceutical companies in relation to access to medicines: The sexual and reproductive health context

Author: Rajat Khosla & Paul Hunt, Human Rights Centre, University of Essex

The application of human rights may vary from one type of actor to another…[T]he logic of human rights will inevitably lead to their application, in one form or another, to non-State actors…This briefing examines the issue of access to medicines in...

Read more

Article
17 August 2006

[PPT] presentation: "Benchmarking AIDS: Evaluating pharmaceutical company responses to the public health crisis in emerging markets"

Author: Daniel Rosan, Program Director for Public Health, Interfaith Center on Corporate Responsibility [USA]

[identifies pharmaceutical best practice in key areas including research, paediatric needs, drug accessibility, reporting, philanthropy, political engagement; rates 15 top pharmaceutical firms on each practice: Abbott Laboratories, AstraZeneca,...

Read more

Article
14 August 2006

New Report: Top pharma companies fail to address industry best practices on HIV/AIDS

Author: Interfaith Center on Corporate Responsibility [USA]

The Interfaith Center on Corporate Responsibility released a comprehensive scorecard evaluating the pharmaceutical industry's efforts in the fight against HIV/AIDS...The ICCR report highlights the large disparities between industry best practices in...

Read more

Company non-response
8 January 2006

Hoffmann-La Roche (part of Roche) did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Hoffman-La Roche - finds none has comprehensive approach.

Read more

Article
10 June 2004

Sexism and the City: High-profile cases are a sign not of more discrimination against women but of less [UK, USA]

Author: Economist

[A]s more women reach higher managerial positions [in London financial firms] and earn more, so their claims have risen. [refers to Hoffman LaRoche (part of Roche), Investec, Merrill Lynch, Schroder Securities]

Read more